Skip to content
★ Sign in to follow
HR

H. Ralph Snodgrass

VistaGen Therapeutics, Inc.
Total declarations
11
Company
1
▲ Purchases (2 ops.)
€13k
▼ Sales (0 ops.)
—

Latest filing published 03 Jan 2022 for VistaGen Therapeutics, Inc., €5,303.

Filing timeline

BuySale
H. Ralph Snodgrass

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+41.6%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

H. Ralph Snodgrass: trading record in brief

H. Ralph Snodgrass is a declared insider of VistaGen Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 11 May 2011 to 31 December 2021, the count stands at 11 filings.

On the market, this insider has only ever bought: 2 purchases, €13k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 share grants and 2 option exercises.

The record was last updated on 3 January 2022 with a share grant (€5,303) in VistaGen Therapeutics, Inc. The last purchase on record was published on 18 August 2021, which is 1,910 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to H. Ralph Snodgrass

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total

11 of 11 declarations